| Literature DB >> 19889539 |
Katherine A Rawls1, P Therese Lang, Jun Takeuchi, Shinichi Imamura, Tyler D Baguley, Christoph Grundner, Tom Alber, Jonathan A Ellman.
Abstract
The development of low muM inhibitors of the Mycobacterium tuberculosis phosphatase PtpA is reported. The most potent of these inhibitors (K(i)=1.4+/-0.3 microM) was found to be selective when tested against a panel of human tyrosine and dual-specificity phosphatases (11-fold vs the highly homologous HCPtpA, and >70-fold vs all others tested). Modeling the inhibitor-PtpA complexes explained the structure-activity relationships observed in vitro and revealed further possibilities for compound development.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19889539 PMCID: PMC2801607 DOI: 10.1016/j.bmcl.2009.10.090
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823